{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:47:30Z","timestamp":1785235650284,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2022M710852"],"award-info":[{"award-number":["2022M710852"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102420"],"award-info":[{"award-number":["82102420"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"crossref","award":["ZR2024QH034"],"award-info":[{"award-number":["ZR2024QH034"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10875-025-01937-4","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T08:09:44Z","timestamp":1759219784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Child with Chronic Mucocutaneous Candidiasis Harbors a Novel Gain-of-Function Mutation in STAT1"],"prefix":"10.1007","volume":"45","author":[{"given":"Yang","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia\u2011Chi","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei\u2011Te","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Lung","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"5","key":"1937_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamadermatol.2024.0617","volume":"160","author":"D Jing","year":"2024","unstructured":"Jing D, Liang G, Li X. Chronic mucocutaneous candidiasis due to STAT1 gene variant. JAMA Dermatol. 2024;160(5):565\u20136.","journal-title":"JAMA Dermatol"},{"issue":"1","key":"1937_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/imr.13300","volume":"322","author":"T Asano","year":"2024","unstructured":"Asano T, Noma K, Mizoguchi Y, Karakawa S, Okada S. Human STAT1 gain of function with chronic mucocutaneous candidiasis: a comprehensive review for strengthening the connection between bedside observations and laboratory research. Immunol Rev. 2024;322(1):81\u201397.","journal-title":"Immunol Rev"},{"issue":"1","key":"1937_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","volume":"36","author":"M Depner","year":"2016","unstructured":"Depner M, Fuchs S, Raabe J, Frede N, Glocker C, Doffinger R, et al. The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1. J Clin Immunol. 2016;36(1):73\u201384.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1937_CR4","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med. 2011;208(8):1635\u201348.","journal-title":"J Exp Med"},{"issue":"2","key":"1937_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.gene.2016.04.006","volume":"586","author":"R Kobbe","year":"2016","unstructured":"Kobbe R, Kolster M, Fuchs S, Schulze-Sturm U, Jenderny J, Kochhan L, et al. Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation. Gene. 2016;586(2):234\u20138.","journal-title":"Gene"},{"issue":"1","key":"1937_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10875-022-01351-0","volume":"43","author":"EW Borgstr\u00f6m","year":"2023","unstructured":"Borgstr\u00f6m EW, Edvinsson M, P\u00e9rez LP, Norlin AC, Enoksson SL, Hansen S, et al. Three adult cases of STAT1 gain-of-function with chronic mucocutaneous candidiasis treated with JAK inhibitors. J Clin Immunol. 2023;43(1):136\u201350.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1937_CR7","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10875-020-00847-x","volume":"40","author":"S Okada","year":"2020","unstructured":"Okada S, Asano T, Moriya K, Boisson-Dupuis S, Kobayashi M, Casanova JL, et al. Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy. J Clin Immunol. 2020;40(8):1065\u201381.","journal-title":"J Clin Immunol"},{"issue":"25","key":"1937_CR8","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1182\/blood-2015-11-679902","volume":"127","author":"J Toubiana","year":"2016","unstructured":"Toubiana J, Okada S, Hiller J, Oleastro M, Lagos Gomez M, Aldave Becerra JC, et al. Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype. Blood. 2016;127(25):3154\u201364.","journal-title":"Blood"},{"key":"1937_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.654406","volume":"12","author":"W Zhang","year":"2021","unstructured":"Zhang W, Chen X, Gao G, Xing S, Zhou L, Tang X, et al. Clinical relevance of gain- and loss-of-function germline mutations in STAT1: a systematic review. Front Immunol. 2021;12:654406.","journal-title":"Front Immunol"},{"issue":"6","key":"1937_CR10","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2019.01.041","volume":"176","author":"P Bacher","year":"2019","unstructured":"Bacher P, Hohnstein T, Beerbaum E, R\u00f6cker M, Blango MG, Kaufmann S, R\u00f6hmel J, Eschenhagen P, Grehn C, Seidel K, et al. Human Anti-fungal Th17 immunity and pathology rely on Cross-Reactivity against Candida albicans. Cell. 2019;176(6):1340\u20131355.e1315.","journal-title":"Cell"},{"issue":"6","key":"1937_CR11","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.jaip.2023.04.015","volume":"11","author":"SG Tangye","year":"2023","unstructured":"Tangye SG, Puel A. The Th17\/IL-17 axis and host defense against fungal infections. J Allergy Clin Immunol Pract. 2023;11(6):1624\u201334.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"1937_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jaci.2020.12.629","volume":"148","author":"S Shafer","year":"2021","unstructured":"Shafer S, Yao Y, Comrie W, Cook S, Zhang Y, Yesil G, Karako\u00e7-Aydiner E, Baris S, Cokugras H, Aydemir S, et al. Two patients with chronic mucocutaneous candidiasis caused by TRAF3IP2 deficiency. J Allergy Clin Immunol. 2021;148(1):256\u2013261.e252.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"1937_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01601-9","volume":"44","author":"K Noma","year":"2023","unstructured":"Noma K, Tsumura M, Nguyen T, Asano T, Sakura F, Tamaura M, et al. Isolated chronic mucocutaneous candidiasis due to a novel duplication variant of IL17RC. J Clin Immunol. 2023;44(1):18.","journal-title":"J Clin Immunol"},{"issue":"8","key":"1937_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-024-01776-9","volume":"44","author":"WT Lei","year":"2024","unstructured":"Lei WT, Lo YF, Tsumura M, Ding JY, Lo CC, Lin YN, et al. Immunophenotyping and therapeutic insights from chronic mucocutaneous candidiasis cases with STAT1 gain-of-function mutations. J Clin Immunol. 2024;44(8):184.","journal-title":"J Clin Immunol"},{"key":"1937_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.983977","volume":"13","author":"M Bloomfield","year":"2022","unstructured":"Bloomfield M, Zentsova I, Milota T, Sediva A, Parackova Z. Immunoprofiling of monocytes in STAT1 gain-of-function chronic mucocutaneous candidiasis. Front Immunol. 2022;13:983977.","journal-title":"Front Immunol"},{"issue":"1","key":"1937_CR16","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10875-019-00688-3","volume":"40","author":"X Chen","year":"2020","unstructured":"Chen X, Xu Q, Li X, Wang L, Yang L, Chen Z, et al. Molecular and phenotypic characterization of nine patients with STAT1 GOF mutations in China. J Clin Immunol. 2020;40(1):82\u201395.","journal-title":"J Clin Immunol"},{"key":"1937_CR17","doi-asserted-by":"crossref","unstructured":"Break TJ, Oikonomou V, Dutzan N, Desai JV, Swidergall M, Freiwald T, Chauss D, Harrison OJ, Alejo J, Williams DW, et al. Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science. 2021;371(6526).","DOI":"10.1126\/science.aay5731"},{"issue":"2","key":"1937_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/mmy\/myaa043","volume":"59","author":"V Ostadi","year":"2021","unstructured":"Ostadi V, Sherkat R, Migaud M, Modaressadeghi SM, Casanova JL, Puel A, et al. Functional analysis of two STAT1 gain-of-function mutations in two Iranian families with autosomal dominant chronic mucocutaneous candidiasis. Med Mycol. 2021;59(2):180\u20138.","journal-title":"Med Mycol"},{"issue":"1","key":"1937_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","volume":"153","author":"M Fischer","year":"2024","unstructured":"Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, von Bismarck P, Bloomfield M, Booth C, Buddingh EP, et al. JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: an ESID\/EBMT-IEWP retrospective study. J Allergy Clin Immunol. 2024;153(1):275\u2013e286218.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1937_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-024-01684-y","volume":"44","author":"L Dotta","year":"2024","unstructured":"Dotta L, Todaro F, Baronio M, Giacomelli M, Pinelli M, Giambarda M, et al. Patients with STAT1 gain-of-function mutations display increased apoptosis which is reversed by the JAK inhibitor ruxolitinib. J Clin Immunol. 2024;44(4):85.","journal-title":"J Clin Immunol"},{"issue":"4","key":"1937_CR21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10875-020-00943-y","volume":"41","author":"B Kayaoglu","year":"2021","unstructured":"Kayaoglu B, Kasap N, Yilmaz NS, Charbonnier LM, Geckin B, Akcay A, et al. Stepwise reversal of immune dysregulation due to STAT1 gain-of-function mutation following ruxolitinib bridge therapy and transplantation. J Clin Immunol. 2021;41(4):769\u201379.","journal-title":"J Clin Immunol"},{"key":"1937_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.928213","volume":"13","author":"Y Xie","year":"2022","unstructured":"Xie Y, Shao F, Lei J, Huang N, Fan Z, Yu H. Case report: a STAT1 gain-of-function mutation causes a syndrome of combined immunodeficiency, autoimmunity and pure red cell aplasia. Front Immunol. 2022;13:928213.","journal-title":"Front Immunol"},{"issue":"1","key":"1937_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.medj.2021.12.003","volume":"3","author":"JM Rosenberg","year":"2022","unstructured":"Rosenberg JM, Peters JM, Hughes T, Lareau CA, Ludwig LS, Massoth LR, Austin-Tse C, Rehm HL, Bryson B, Chen YB, et al. JAK Inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia. Med. 2022;3(1):42\u2013e5745.","journal-title":"Med"},{"key":"1937_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1430938","volume":"15","author":"FM Fink","year":"2024","unstructured":"Fink FM, H\u00f6pfl R, Witsch-Baumgartner M, Kropshofer G, Martin S, Fink V, et al. Retrospective identification of the first cord blood-transplanted severe aplastic anemia in a STAT1-associated chronic mucocutaneous candidiasis family: case report, review of literature and pathophysiologic background. Front Immunol. 2024;15:1430938.","journal-title":"Front Immunol"},{"key":"1937_CR25","doi-asserted-by":"crossref","unstructured":"Li J, Ritelli M, Ma CS, Rao G, Habib T, Corvilain E, et al. Chronic mucocutaneous candidiasis and connective tissue disorder in humans with impaired JNK1-dependent responses to IL-17A\/F and TGF-\u03b2. Sci Immunol. 2019;4(41).","DOI":"10.1126\/sciimmunol.aax7965"},{"issue":"1","key":"1937_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1100102","volume":"365","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk FL, Plantinga TS, Hoischen A, Smeekens SP, Joosten LA, Gilissen C, Arts P, Rosentul DC, Carmichael AJ, Smits-van der Graaf CA, et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med. 2011;365(1):54\u201361.","journal-title":"N Engl J Med"},{"key":"1937_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01433","volume":"10","author":"O Zimmerman","year":"2019","unstructured":"Zimmerman O, Olbrich P, Freeman AF, Rosen LB, Uzel G, Zerbe CS, et al. STAT1 gain-of-function mutations cause high total STAT1 levels with normal dephosphorylation. Front Immunol. 2019;10:1433.","journal-title":"Front Immunol"},{"issue":"6","key":"1937_CR28","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.jaci.2017.08.040","volume":"141","author":"A Vargas-Hern\u00e1ndez","year":"2018","unstructured":"Vargas-Hern\u00e1ndez A, Mace EM, Zimmerman O, Zerbe CS, Freeman AF, Rosenzweig S, Leiding JW, Torgerson T, Altman MC, Schussler E, et al. Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations. J Allergy Clin Immunol. 2018;141(6):2142\u20132155.e2145.","journal-title":"J Allergy Clin Immunol"},{"key":"1937_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.557521","volume":"11","author":"K Nemoto","year":"2020","unstructured":"Nemoto K, Kawanami T, Hoshina T, Ishimura M, Yamasaki K, Okada S, et al. Impaired b-cell differentiation in a patient with STAT1 gain-of-function mutation. Front Immunol. 2020;11:557521.","journal-title":"Front Immunol"},{"issue":"703","key":"1937_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade7028","volume":"15","author":"AD Largent","year":"2023","unstructured":"Largent AD, Lambert K, Chiang K, Shumlak N, Liggitt D, Oukka M, et al. Dysregulated IFN-\u03b3 signals promote autoimmunity in STAT1 gain-of-function syndrome. Sci Transl Med. 2023;15(703):eade7028.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1937_CR31","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaci.2016.09.035","volume":"140","author":"R Kagawa","year":"2017","unstructured":"Kagawa R, Fujiki R, Tsumura M, Sakata S, Nishimura S, Itan Y, et al. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants. J Allergy Clin Immunol. 2017;140(1):232\u201341.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"1937_CR32","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.jaci.2013.01.052","volume":"131","author":"EP Sampaio","year":"2013","unstructured":"Sampaio EP, Hsu AP, Pechacek J, Bax HI, Dias DL, Paulson ML, Chandrasekaran P, Rosen LB, Carvalho DS, Ding L, et al. Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis. J Allergy Clin Immunol. 2013;131(6):1624\u201334.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1937_CR33","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1189\/jlb.0513250","volume":"95","author":"Y Mizoguchi","year":"2014","unstructured":"Mizoguchi Y, Tsumura M, Okada S, Hirata O, Minegishi S, Imai K, et al. Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis. J Leukoc Biol. 2014;95(4):667\u201376.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"1937_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-021-00196-7","volume":"6","author":"O Scott","year":"2021","unstructured":"Scott O, Lindsay K, Erwood S, Mollica A, Roifman CM, Cohn RD, et al. STAT1 gain-of-function heterozygous cell models reveal diverse interferon-signature gene transcriptional responses. NPJ Genom Med. 2021;6(1):34.","journal-title":"NPJ Genom Med"},{"issue":"1","key":"1937_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13694","volume":"33","author":"O Scott","year":"2022","unstructured":"Scott O, Dadi H, Vong L, Pasternak Y, Garkaby J, Willett Pachul J, et al. DNA-binding domain mutations confer severe outcome at an early age among STAT1 gain-of-function patients. Pediatr Allergy Immunol. 2022;33(1):e13694.","journal-title":"Pediatr Allergy Immunol"},{"key":"1937_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.rmed.2017.03.018","volume":"126","author":"O Breuer","year":"2017","unstructured":"Breuer O, Daum H, Cohen-Cymberknoh M, Unger S, Shoseyov D, Stepensky P, et al. Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis. Respir Med. 2017;126:39\u201345.","journal-title":"Respir Med"},{"issue":"Suppl","key":"1937_CR37","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1016\/j.jinf.2016.04.023","volume":"72","author":"FL van de Veerdonk","year":"2016","unstructured":"van de Veerdonk FL, Netea MG. Treatment options for chronic mucocutaneous candidiasis. J Infect. 2016;72(Suppl):S56\u201360.","journal-title":"J Infect"},{"issue":"5","key":"1937_CR38","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10875-022-01257-x","volume":"42","author":"A Dey\u00e0-Mart\u00ednez","year":"2022","unstructured":"Dey\u00e0-Mart\u00ednez A, Rivi\u00e8re JG, Roxo-Junior P, Ramakers J, Bloomfield M, Guisado Hernandez P, et al. Impact of JAK inhibitors in pediatric patients with STAT1 gain of function (GOF) mutations-10 children and review of the literature. J Clin Immunol. 2022;42(5):1071\u201382.","journal-title":"J Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01937-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-025-01937-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-025-01937-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:45:20Z","timestamp":1777304720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-025-01937-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1007\/s10875-025-01937-4","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and\u00a0approved by the ethics committee of Shandong Provincial Hospital, affiliated to Shandong First Medical University. The patients provided written informed consent for participation in the study and publication of potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"137"}}